magnolol
chemical compound
≈ 2 min read
Names in other languages
- فارسیلینوالیدیک اسید
- ItalianoMagnololo
- Češtinamagnolol
- Englishmagnolol
- EnglishMagnolol
- EnglishMagnolol
- shMagnolol
- СрпскиMagnolol
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Magnolol is an organic compound that is classified as lignan. It is a bioactive compound found in the bark of the Houpu magnolia (Magnolia officinalis) and in M. grandiflora. Magnolol is a compound that acts on GABA A receptors and functions as an allosteric modulator.
It has antifungal properties and demonstrates anti-periodontal disease effects in animal models. In cell cultures, magnolol stimulates osteoblasts and inhibits osteoclasts, indicating potential for anti-osteoporosis treatment. It also binds in a dimeric form to PPARγ, acting as an agonist of this nuclear receptor.
Additionally, magnolol may interact with cannabinoid receptors, acting as a partial agonist of CB2 receptors with lower affinity for CB1 receptors.
Magnolol is an organic compound that is classified as lignan. It is a bioactive compound found in the bark of the Houpu magnolia (Magnolia officinalis) and in M. grandiflora. Magnolol is a compound that acts on GABA A receptors and functions as an allosteric modulator.
It has antifungal properties and demonstrates anti-periodontal disease effects in animal models. In cell cultures, magnolol stimulates osteoblasts and inhibits osteoclasts, indicating potential for anti-osteoporosis treatment. It also binds in a dimeric form to PPARγ, acting as an agonist of this nuclear receptor.
Additionally, magnolol may interact with cannabinoid receptors, acting as a partial agonist of CB2 receptors with lower affinity for CB1 receptors.
Bioactivity
It is known to act on the GABA A receptors in rat cells in vitro as well as having antifungal properties. Magnolol has a number of osteoblast-stimulating and osteoclast-inhibiting activities in cell culture and has been suggested as a candidate for screening for anti-osteoporosis activity. It has anti-periodontal disease activity in a rat model.
Structural analogues have been studied and found to be strong allosteric modulators of GABA A . Magnolol is also binding in dimeric mode to PPARγ, acting as an agonist of this nuclear receptor. Magnolol may interact with cannabinoid receptors, acting as a partial agonist of CB 2 receptors, with lower affinity for the CB 1 receptor.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368884168 under CC BY-SA 4.0; modifications have been made.